We develop proprietary drug delivery technologies and drug formulas in the field of oncology, dermatology and autoimmune diseases.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 5, 2021 | Non-Equity Assistant | — | 1 |
Google for Startups
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Google for Startups
|
Yes | Non-Equity Assistant |